January 3, 2020 Eli Lilly and Company Center: Brain Tumor Status:Closed A Phase 2 Study of Abemaciclib in Patients With Brain Metastases Secondary to Hormone Receptor Positive Breast Cancer, Non-small Cell Lung Cancer, or Melanoma